Most Cited Papers In Last Two Years

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Mechanobiology in the development and progression of nonalcoholic fatty liver disease: an updated review

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Commentary: Of women, liver, and heart

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

Long COVID-19 and diabetes mellitus: a short review

Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways

Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm

Metabolic bariatric surgery in face of new anti-obesity medications-10 + 1 challenges

Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention

Ultrasonographic fatty liver indicator (US-FLI): a reliable biomarker for non-invasive NAFLD stratification

Pharmacological management of type 2 diabetes: clinical considerations and future perspectives

Onion-skin type of periductular sclerosis in mice with genetic deletion of biliary kindlin-2 as tight junction stabilizer: a pilot experiment indicating a primary sclerosing cholangitis (PSC) phenotype

Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction